Anbio Biotechnology
NNNN
$6.61
$0.040.61%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.37% | -2.37% | 11.75% | 11.75% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.28% | -16.28% | -15.10% | -15.10% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.24% | 12.24% | -32.65% | -32.65% | -- |
| Total Current Assets | 23.89% | 23.89% | 12.96% | 12.96% | -- |
|
|
|||||
| Total Current Assets | 23.89% | 23.89% | 12.96% | 12.96% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -36.05% | -36.05% | 1,970.00% | 1,970.00% | -- |
| Total Assets | 22.79% | 22.79% | 13.28% | 13.28% | -- |
|
|
|||||
| Total Accounts Payable | -63.38% | -63.38% | -41.25% | -41.25% | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -7.10% | -7.10% | 990.63% | 990.63% | -- |
| Total Other Current Liabilities | -7.10% | -7.10% | 990.63% | 990.63% | -- |
| Total Current Liabilities | -60.66% | -60.66% | -29.63% | -29.63% | -- |
|
|
|||||
| Total Current Liabilities | -60.66% | -60.66% | -29.63% | -29.63% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -60.66% | -60.66% | -29.63% | -29.63% | -- |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | -- | -- | -- |
| Retained Earnings | 30.78% | 30.78% | 17.96% | 17.96% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 30.74% | 30.74% | 18.11% | 18.11% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.74% | 30.74% | 18.11% | 18.11% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.74% | 30.74% | 18.11% | 18.11% | -- |
|
|
|||||